Geissler, Julia http://orcid.org/0000-0003-1878-9647
Jans, Thomas
Banaschewski, Tobias
Becker, Katja
Renner, Tobias
Brandeis, Daniel
Döpfner, Manfred
Dose, Christina
Hautmann, Christopher
Holtmann, Martin
Jenkner, Carolin
Millenet, Sabina
Romanos, Marcel
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01EE1408C)
Article History
Received: 31 January 2018
Accepted: 10 April 2018
First Online: 27 April 2018
Ethics approval and consent to participate
: The ESCAadol study is approved by the Ethics Committees of the Medical Faculty of the University of Würzburg, Germany (No. 141/15), the Faculty of Medicine of the Ruhr-University Bochum, Germany (No. 15-5539), the Medical Faculty of the University of Köln, Germany (No. 15-425), the Medical Faculty Mannheim at Heidelberg University, Germany (No. 215-645 N-MA), the Faculty of Medicine at the Philipps-University Marburg, Germany (No. 169/15) and the Faculty of Medicine of the Eberhard-Karls-University Tübingen, Germany (No. 744/2015BO2).In order to participate in the study, the adolescent participant and both parents (in case of joint custody) are first briefed extensively either in person or via telephone about the study procedures and goals. The family then receives the information in written form per mail prior to the first appointment. At the beginning of the screening appointment, a member of the study coordination team is present to answer any open questions and assess whether all parties voluntarily participate. Then, written informed consent is obtained and the screening begins.
: TB served in an advisory or consultancy role for Actelion, Hexal Pharma, Lilly, Lundbeck, Medice, Novartis, and Shire. He received conference support or speaker’s fees from Lilly, Medice, Novartis, and Shire. He is/has been involved in clinical trials conducted by Shire and Viforpharma. He received royalties from Hogrefe, Kohlhammer, CIP Medien, and Oxford University Press. The present work is unrelated to the above grants and relationships.KB has been involved in research/clinical trials with Eli Lilly (≤ 2011) and Shire (≤ 2010), was on the Advisory Board of Eli Lilly/Germany (≤ 2014), a member of the Scientific Committee of Shire (≤ 2012) and was paid for public speaking by Eli Lilly (< 2011) and Shire (2015).DB serves as an unpaid scientific advisor for an EU-funded neurofeedback trial unrelated to the present work.MD received consulting income and research support from Lilly, Medice, Shire, Janssen Cilag, Novartis, and Vifor. He received income as Head of the School for Child and Adolescent Behaviour Therapy at the University of Köln and royalties from treatment manuals, books and psychological tests published by Guilford, Hogrefe, Enke, Beltz, and Huber.MH served in an advisory or consultancy role for Lilly, Shire and Medice, and received conference attendance support or was paid for public speaking by Medice, Neuroconn, and Shire.JG, CH, TJ, TR, CD, CJ, SM and MR declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.